Mercator MedSystems, Inc., is a medical technology company focused on the treatment of peripheral artery disease utilizing its catheter-guided, microfluid injection systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. The Company’s technology also enables the commercialization of novel therapeutics for other vascular diseases, hypertension, oncology, and regenerative medicine.

U.S. Department of the Treasury

Crocker Capital

Palo Alto Investors

Volcano Capital

Aphelion Capital

Shenzhen Salubris Pharmaceuticals

Mercator MedSystems, Inc.

Mercator MedSystems, Inc. is a medical device company focused on the clinical and commercial development of FDA cleared and CE marked, catheter-based, Micro-infusion technologies, including the Bullfrog® Micro-Infusion Device for the local delivery of pharmacologics and biologics to the peripheral vasculature. The company is currently conducting clinical studies in Deep Vein Thrombosis (DVT) and Below the Knee (BTK) Peripheral Arterial Disease (PAD).

COM:MERCATORMED

Mercator MedSystems, Inc.

Filings Not Available